Honest Company Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Honest Company Inc trades at $4.99 (market cap $533.20M), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.63 (market cap $2.27B). The key difference: SELLAS Life Sciences Group Inc. Common Stock is far larger — about 4.3× Honest Company Inc's market cap, and SELLAS Life Sciences Group Inc. Common Stock is more actively traded (4,179,659 versus 1,990,155). Which is the better fit depends on your goals.
| HNST | SLS | |
|---|---|---|
Market Cap | $533.20M | $2.27B |
Volume | 1,990,155 | 4,179,659 |
Sector | Consumer Staples | Health |
52-Week High | $5.95 | $15.46 |
52-Week Low | $2.10 | $1.39 |
Typical Hold Time | 39 Days | — |
Enterprise Value | $436.81M | $2.14B |
Signals from Pluang's Aura AI — not financial advice
HNST trades at $4.99, up 1.22% today, with a bearish technical signal despite recent positive earnings momentum. The company shows mixed fundamentals with revenue of $371.32M in 2025 but negative net income margins. Recent Q2 2026 earnings beat expectations with $0.04 EPS, and institutional interest is growing with BlackRock's $25.66M investment in August 2026.
The stock faces headwinds from persistent unprofitability and declining revenue projections for 2026, though strategic exits are improving margins. Analyst consensus is mixed with a $5.30 price target, suggesting limited upside. Key risks include execution on profitability and competitive pressures in personal care markets.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
The Honest Co Inc is a consumer products company. It offers eco-friendly diapers and a natural line of bath, skincare, home cleaning, and organic nutritional supplement products and other products.
Read more on HNST →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →